Group items tagged

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

Surrogacy is a path that many couples who are unable to have children of their own have chosen due to the intimacy and experiences involved in the process. There are many things that should be taken into consideration before you make the choice of becoming a surrogate mother. You should first speak with an attorney and/or an adoption agency specializing in surrogacy. They can provide you with a list of things to consider and agencies available to start you on your way, educate you on your rights as well as those of the adoptive couple and what you can expect and what is expected out of you. When you consider on becoming a surrogate mother, you also need to decide whether you will be an independent surrogate or agency surrogate. As an independent surrogate, you need to be responsible for your own arrangements, finding the right couple, working out a contract and, if anything goes awry with the arrangements, you will be responsible for finding another couple. As an agency surrogate, all of these arrangements and legalities are managed for you by your agent. Either route you choose, make sure that you have consulted an attorney who specializes in surrogacy and adoption to serve your best interests. The next step in becoming a surrogate involves the physical aspects or extent of the measures you are willing to take to become pregnant. You need to decide if you are willing to undergo artificial insemination, hormone therapy and/or in vitro fertilization. Each of these measures are time consuming and not fail proof, so it is always best to have an alternate plan, if possible, in case your first choice for conception does not work. Finally, once an agency or attorney is employed in your journey to becoming a surrogate mother, psychological and physical tests need to be done to make sure that you are healthy enough to carry a child to term and that there are not any past medical or family histories that may cause pregnancy or genetic issues. Extensive counseling will be